Literature DB >> 27398799

Insights into the Mechanisms of the Acute Kidney Injury-to-Chronic Kidney Disease Continuum.

Koji Takaori1, Motoko Yanagita.   

Abstract

Acute kidney injury (AKI) is an increasingly common clinical problem with significant impact on long-term patient outcome. Recent clinical trials demonstrate that AKI is closely related to the progression of chronic kidney disease (CKD) and end-stage renal disease, though the precise mechanisms linking AKI to CKD remain unclear. While inflammation, microvascular rarefaction and hypoxia are involved in the AKI-to-CKD continuum, proximal tubule injury seems to play an important role in the progression of CKD. In this review, we focus on the mechanisms of the AKI-to-CKD continuum, especially the mechanism by which injury to the proximal tubules triggers progression to CKD. Elucidating the mechanisms involved in the AKI-to-CKD continuum will support the development of therapeutic options to prevent progression from AKI to CKD.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27398799     DOI: 10.1159/000448081

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  11 in total

1.  Deceased-donor acute kidney injury is not associated with kidney allograft failure.

Authors:  Isaac E Hall; Enver Akalin; Jonathan S Bromberg; Mona D Doshi; Tom Greene; Meera N Harhay; Yaqi Jia; Sherry G Mansour; Sumit Mohan; Thangamani Muthukumar; Peter P Reese; Bernd Schröppel; Pooja Singh; Heather R Thiessen-Philbrook; Francis L Weng; Chirag R Parikh
Journal:  Kidney Int       Date:  2018-11-20       Impact factor: 10.612

2.  Patient outcomes following AKI and AKD: a population-based cohort study.

Authors:  Huan Wang; Emilie Lambourg; Bruce Guthrie; Daniel R Morales; Peter T Donnan; Samira Bell
Journal:  BMC Med       Date:  2022-07-20       Impact factor: 11.150

3.  Exosomal mitochondrial tRNAs and miRNAs as potential predictors of inflammation in renal proximal tubular epithelial cells.

Authors:  Glory Ranches; Maximilian Zeidler; Roman Kessler; Martina Hoelzl; Michael W Hess; Jonathan Vosper; Paul Perco; Herbert Schramek; Kai K Kummer; Michaela Kress; Anne Krogsdam; Michael Rudnicki; Gert Mayer; Alexander Huettenhofer
Journal:  Mol Ther Nucleic Acids       Date:  2022-05-04       Impact factor: 10.183

4.  Identification and classification of epithelial cells in nephron segments by actin cytoskeleton patterns.

Authors:  Girishkumar Kaitholil Kumaran; Israel Hanukoglu
Journal:  FEBS J       Date:  2019-11-01       Impact factor: 5.542

5.  Combined melatonin and poricoic acid A inhibits renal fibrosis through modulating the interaction of Smad3 and β-catenin pathway in AKI-to-CKD continuum.

Authors:  Dan-Qian Chen; Gang Cao; Hui Zhao; Lin Chen; Tian Yang; Ming Wang; Nosratola D Vaziri; Yan Guo; Ying-Yong Zhao
Journal:  Ther Adv Chronic Dis       Date:  2019-08-14       Impact factor: 5.091

6.  Combined Blockade of Smad3 and JNK Pathways Ameliorates Progressive Fibrosis in Folic Acid Nephropathy.

Authors:  Mengjie Jiang; Jinjin Fan; Xinli Qu; Songhui Li; Susan K Nilsson; Yu Bo Yang Sun; Yaping Chen; Di Yu; Dan Liu; Bi-Cheng Liu; Mingliang Tang; Wei Chen; Yi Ren; David J Nikolic-Paterson; Xiaoyun Jiang; Jinhua Li; Xueqing Yu
Journal:  Front Pharmacol       Date:  2019-08-09       Impact factor: 5.810

7.  Impact of deceased donor with acute kidney injury on subsequent kidney transplant outcomes-an ANZDATA registry analysis.

Authors:  Juan Pei; Yeoungjee Cho; Yong Pey See; Elaine M Pascoe; Andrea K Viecelli; Ross S Francis; Carolyn van Eps; Nicole M Isbel; Scott B Campbell; Philip A Clayton; Jeremy Chapman; Michael Collins; Wai Lim; Wen Tang; Germaine Wong; Carmel M Hawley; David W Johnson
Journal:  PLoS One       Date:  2021-03-25       Impact factor: 3.240

Review 8.  Late renal toxicity of treatment for childhood malignancy: risk factors, long-term outcomes, and surveillance.

Authors:  Roderick Skinner
Journal:  Pediatr Nephrol       Date:  2017-04-22       Impact factor: 3.714

9.  Advances in Chronic Kidney Disease.

Authors:  Alan R Parrish
Journal:  Int J Mol Sci       Date:  2016-08-11       Impact factor: 5.923

Review 10.  Inhibition of Soluble Epoxide Hydrolase for Renal Health.

Authors:  Jun-Yan Liu
Journal:  Front Pharmacol       Date:  2019-01-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.